Microbot Medical Inc. (MBOT) — insider trading
Health Care · NASDAQ
Microbot Medical Inc. (MBOT) has 14 reported SEC Form 4 insider transactions in our data (latest 2026-04-01).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-04-01 | Laxminarain Prattipati | Director | Grant / award / vesting (derivative) | 10,000 | $0.00 | $0 | Form 4 |
| 2026-04-01 | Burell Scott R | Director | Grant / award / vesting (derivative) | 10,000 | $0.00 | $0 | Form 4 |
| 2026-04-01 | Wilson David James | Director | Grant / award / vesting (derivative) | 10,000 | $0.00 | $0 | Form 4 |
| 2026-04-01 | Wenderow Tal Baruch | Director | Grant / award / vesting (derivative) | 10,000 | $0.00 | $0 | Form 4 |
| 2026-04-01 | Madden Martin J. | Director | Grant / award / vesting (derivative) | 10,000 | $0.00 | $0 | Form 4 |
| 2026-04-01 | Stockburger Aileen Ptucha | Director | Grant / award / vesting (derivative) | 10,000 | $0.00 | $0 | Form 4 |
| 2026-02-18 | Vaknin Rachel | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 105,000 | $0.00 | $0 | Form 4 |
| 2026-02-18 | Sharon Simon | Officer (General Manager, CTO) | Grant / award / vesting (derivative) | 105,000 | $0.00 | $0 | Form 4 |
| 2026-02-18 | Diaz-Cartelle Juan | Officer (Chief Medical Officer) | Grant / award / vesting (derivative) | 105,000 | $0.00 | $0 | Form 4 |
| 2026-02-18 | Gadot Harel | Director, Officer (Chairman, President and CEO) | Grant / award / vesting (derivative) | 480,000 | $0.00 | $0 | Form 4 |
| 2025-02-05 | Gadot Harel | Director, Officer (Chairman, President and CEO) | Grant / award / vesting (derivative) | 228,000 | $0.00 | $0 | Form 4 |
| 2025-02-05 | Vaknin Rachel | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 48,125 | $0.00 | $0 | Form 4 |
| 2024-02-26 | Gadot Harel | Director, Officer (Chairman, President and CEO) | Grant / award / vesting (derivative) | 12,000 | $0.00 | $0 | Form 4 |
| 2024-02-26 | Vaknin Rachel | Officer (Chief Financial Officer) | Grant / award / vesting (derivative) | 4,375 | $0.00 | $0 | Form 4 |
Ask the chat about MBOT's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Microbot Medical Inc. (MBOT).
Last updated 2026-04-01 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.